Skip to Content

Trees Corp CANN

Morningstar Rating
$0.06 −0.01 (9.18%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CANN is trading at a 376% premium.
Price
$0.06
Fair Value
$4.46
Uncertainty
Extreme
1-Star Price
$2.33
5-Star Price
$3.42
Economic Moat
Dmkzr
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CANN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.07
Day Range
$0.060.08
52-Week Range
$0.040.20
Bid/Ask
$0.06 / $0.08
Market Cap
$6.97 Mil
Volume/Avg
56,702 / 118,875

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.44
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Trees Corp is a vertically integrated cannabis company and multi-state operator in the United States. It has two segments Retail and Cultivation. It is pursuing a roll-up plan of licensed assets in mature markets while maintaining loyal, local customer bases. TREES owns and operates a light-deprivation greenhouse and a campus of indoor cultivation facilities in Boulder, dispensaries in Englewood, Longmont, and Berthoud, Colorado, and three dispensaries in Portland, Oregon.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
91

Valuation

Metric
CANN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.44
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CANN
Quick Ratio
0.06
Current Ratio
0.22
Interest Coverage
−1.42
Quick Ratio
CANN

Profitability

Metric
CANN
Return on Assets (Normalized)
−20.47%
Return on Equity (Normalized)
−1,199.98%
Return on Invested Capital (Normalized)
−15.62%
Return on Assets
CANN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
HncfqvwkcRsc$78.1 Bil
Merck KGaA ADR
MKKGY
VsswpdzqrFzdsx$77.8 Bil
Haleon PLC ADR
HLN
QlrkmcpqGrll$38.6 Bil
Viatris Inc
VTRS
LwgvdwrCqlh$12.5 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
VbnkdmnvvDbm$12.0 Bil
Catalent Inc
CTLT
JjyqqkxhFzmmg$10.2 Bil
Perrigo Co PLC
PRGO
LmxyvfzlZfzkx$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
MzxlsqrYhqxm$3.5 Bil
Curaleaf Holdings Inc
CURLF
QdwsdwnxkKqjky$3.0 Bil
Green Thumb Industries Inc
GTBIF
KqfbrjhrxkLgdxv$2.8 Bil

Sponsor Center